These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 16490861)

  • 21. Levofloxacin-induced toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Teo WL; Pang SM
    Ann Acad Med Singap; 2010 Aug; 39(8):660-1. PubMed ID: 20838711
    [No Abstract]   [Full Text] [Related]  

  • 22. Stevens Johnson syndrome in association with Mycoplasma pneumonia.
    Manwani NS; Balasubramanian S; Dhanalakshmi K; Sumanth A
    Indian J Pediatr; 2012 Aug; 79(8):1097-9. PubMed ID: 22012144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IVIG for the treatment of toxic epidermal necrolysis.
    Mittmann N; Chan BC; Knowles S; Shear NH
    Skin Therapy Lett; 2007 Feb; 12(1):7-9. PubMed ID: 17361314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ofloxacin eyedrops-induced toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Parmar NV; Kuruvila S; Ganguly S; Krishna CV
    Int J Dermatol; 2014 Nov; 53(11):e547-8. PubMed ID: 25209837
    [No Abstract]   [Full Text] [Related]  

  • 25. Late-onset and long-term systemic dyshidrotic eczema after intravenous immunoglobulin treatment for Kawasaki disease.
    Yokoyama K; Yoshida A
    BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30902846
    [No Abstract]   [Full Text] [Related]  

  • 26. [Stevens-Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulins].
    Yuste M; Sánchez-Estella J; Santos JC; Alonso MT; Bordel MT; Gutiérrez JL; Zamora T
    Actas Dermosifiliogr; 2005 Nov; 96(9):589-92. PubMed ID: 16476303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous immunoglobulins for the management of Stevens-Johnson syndrome with minimal skin manifestations.
    Zipitis CS; Thalange N
    Eur J Pediatr; 2007 Jun; 166(6):585-8. PubMed ID: 17008995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The timing of intravenous immunoglobulin therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Yeung CK; Lam LK; Chan HH
    Clin Exp Dermatol; 2005 Sep; 30(5):600-2. PubMed ID: 16045716
    [No Abstract]   [Full Text] [Related]  

  • 29. Pompholyx after intravenous immunoglobulin therapy for treatment of Guillain-Barré syndrome.
    Rhee DY; Park GH; Chang SE; Lee MW; Choi JH; Moon KC; Koh JK
    J Eur Acad Dermatol Venereol; 2009 May; 23(5):602-4. PubMed ID: 18761548
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.
    Gürcan HM; Ahmed AR
    Ann Pharmacother; 2007 May; 41(5):812-23. PubMed ID: 17440006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pompholyx and eczematous reactions associated with intravenous immunoglobulin therapy.
    Gerstenblith MR; Antony AK; Junkins-Hopkins JM; Abuav R
    J Am Acad Dermatol; 2012 Feb; 66(2):312-6. PubMed ID: 21601310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study.
    Schneck J; Fagot JP; Sekula P; Sassolas B; Roujeau JC; Mockenhaupt M
    J Am Acad Dermatol; 2008 Jan; 58(1):33-40. PubMed ID: 17919775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxic epidermal necrolysis and co-existent SARS-CoV-2 (COVID-19) treated with intravenous immunoglobulin: 'Killing 2 birds with one stone'.
    Saha M; D'Cruz A; Paul N; Healy R; Collins D; Charles DA; Sahu S; Fonia A
    J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):e97-e98. PubMed ID: 32805059
    [No Abstract]   [Full Text] [Related]  

  • 34. [The new domestic immunoglobulin G gabriglobin in complex therapy of immunodeficiency states and infectious pathology].
    Pas'ko VG; Latysheva TV; Nikiforov VV; Mostovskaia EV; Denisov AK; Kondrashin IuI
    Voen Med Zh; 2006 Jul; 327(7):40-2. PubMed ID: 16977880
    [No Abstract]   [Full Text] [Related]  

  • 35. Plasmapheresis as adjuvant therapy in Stevens-Johnson syndrome and hepatic encephalopathy.
    Hung PC; Wang HS; Hsia SH; Wong AM
    Brain Dev; 2014 Apr; 36(4):356-8. PubMed ID: 23777679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of intravenous immunoglobulin in toxic epidermal necrolysis.
    Feldmeyer L; Kerdel FA; French LE
    Arch Dermatol; 2011 Dec; 147(12):1440-1. PubMed ID: 22184768
    [No Abstract]   [Full Text] [Related]  

  • 37. Appropriate use of intravenous immunoglobulin in neonatal neutropenia.
    Buenz EJ; Howe CL
    J Perinatol; 2007 Mar; 27(3):196-7; author reply 197. PubMed ID: 17314992
    [No Abstract]   [Full Text] [Related]  

  • 38. Giving intravenous immunoglobulin.
    Scherf R; White-Reid K
    RN; 2008 Jan; 71(1):29-34; quiz 35. PubMed ID: 18271361
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute hemolysis secondary to high-dose intravenous immunoglobulin in a patient with Stevens-Johnson syndrome.
    Shakouri AA; Bahna SL
    Ann Allergy Asthma Immunol; 2012 Jun; 108(6):463-4. PubMed ID: 22626604
    [No Abstract]   [Full Text] [Related]  

  • 40. [Mycoplasma pneumoniae is not a respiratory pathogen only: two case reports of ''atypical'' clinical presentations].
    De Donno V; La Dolcetta M; Fissore MF; Benech P; Peduto A; Maddaluno S; Alpicrovi C; Chiossi M
    Minerva Pediatr; 2008 Feb; 60(1):135-9. PubMed ID: 18277372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.